Express Pharma
Express Pharma
Browsing tag
HER2-positive breast cancer
CDSCO approves Trastuzumab Deruxtecan for first-line HER2-positive breast cancer
Read more
Daiichi Sankyo will remain dominant in ADC market for oncology treatments: GlobalData
Read more
Glenmark reduces cost of Trastuzumab treatment in India
Read more